Progyny CEO Details Utilization Trends, Forecasting and Progyny Select Fully Insured Rollout at Conference

Core Insights - Progyny's CEO, Pete Anevski, discussed utilization trends and forecasting during a fireside chat, emphasizing the importance of actual benefit use over eligibility counts [4][2] - The company is launching a new fully insured product, Progyny Select, aimed at small group employers, with expectations to go live in 2027 [6][12] Utilization Trends - Anevski highlighted that utilization rates have remained stable historically, ranging from approximately 1.03% to 1.09%, and emphasized that the company focuses on actual benefit usage rather than fluctuating eligibility counts [2][7] - The first quarter typically sees the highest proportion of individuals beginning their fertility journey, with treatment activity often occurring in subsequent quarters [5][1] Forecasting Methodology - Progyny utilizes client history, industry patterns, and member journey signals to predict utilization, with Q1 consultations leading to higher-revenue treatments in Q2 through Q4 [5][8] - The company acknowledges that 2024 may present unique challenges, including a mid-year dip in utilization influenced by the political environment [10] Progyny Select Rollout - The fully insured small-group product will be marketed through brokers and PEOs, with a focus on signing distributors and training brokers ahead of the critical fourth-quarter renewal season [11][12] - The product is designed with risk management features, including IVF-only coverage and lifetime caps, to control utilization risk [6][14] Competitive Landscape - Anevski noted that the recent selling season did not feel more competitive than previous years, with Progyny continuing to win the majority of contracts against competitors [19] - Some competitors have faced challenges, including bankruptcy, which has created opportunities for Progyny to strengthen its market position [19] Technology Investments - Progyny is investing in AI and data technology to enhance services for stakeholders, aiming to reduce friction for patients and improve operational efficiency [17][18] - The company believes that technology can support provider partnerships and potentially lower costs, thereby enhancing its negotiating position [18]